IM Cannabis (IMCC)
Importer, brand manager and pharmacy distributor of medical cannabis in Israel and Germany.
Something off on this page? Send us feedback.
Imports, brands and distributes medical cannabis in Israel and Germany, selling mostly flower through pharmacies, retail and online channels. The German Adjupharm platform handles the regulated import-to-pharmacy chain and supplies most continuing revenue.
Imports medical cannabis from licensed suppliers in Israel, markets IMC, Roma, WAGNERS, BLKMKT, LOT420, PICO, Flower and TOKEN, and reaches patients through pharmacies, owned retail stores and online channels. Dried flower is the central product, alongside selected oils and extracts.
Runs the German operation through Adjupharm, which imports, processes and distributes products to licensed pharmacies. Its logistics center handles storage, repackaging, stability testing, batch release and distribution. Germany provides most continuing revenue; Israel supplies the remainder, and no U.S. cannabis activities are reported.
Depends on pharmacy, narcotics, wholesale, import and other regulated licenses, EU-GMP suppliers, contracted packagers and international logistics. The pending European-asset sale to an entity controlled by the CEO is non-binding.
Company facts
No analyst consensus on record.
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $1.2M · Total debt $9.9M · Total assets $17.6M · Shareholders' equity −$3.9M
- Revenue
- $5.4M
- Operating income
- −$1.5M
- Net income
- −$3.1M
Reported in CAD, converted at the latest exchange rate
No dividends on record.
| Institutions | 0.13% | 12.0K shares | |
|---|---|---|---|
| 12 holders · as of Jun 30, 2026 | |||
institutions as of Jun 30, 2026 · holders as of their latest filing
No reliable share count is available for this listing, so stakes are shown as shares, not percentages.
The institutional percentage is the one reported with the filings, not one recomputed on the share count here.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
HRT Financial LPInstitution | — | 220,342 | as of Jun 30, 2026 |
Citadel Advisors LLCInstitution | — | 50,655 | as of Jun 30, 2026 |
Jane Street Group, LLCInstitution | — | 37,895 | as of Jun 30, 2026 |
Stonex Group Inc.Institution | — | 23,215 | as of Jun 30, 2026 |
Hidden Cove Wealth Management, LLCInstitution | — | 14,290 | as of Jun 30, 2026 |
Insider tradesForm 4
Nothing filed in the last 12 months.
- Tilray Brands
German medical-cannabis cultivation and pharmacy distribution.
- Aurora Cannabis
German medical-cannabis flower and EU-GMP supply.
- InterCure
Israeli medical-cannabis brands, retail pharmacies, and German access.
ComparePre-market
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| IM Cannabis | $4.69 | +54.24% | $1.9M | — | — | 0.1 | −42.1% |
| Tilray Brands | $4.10 | +0.74% | $456.3M | — | — | 0.4 | +25.5% |
| Aurora Cannabis | $3.99 | −0.87% | $249.6M | — | — | 1.2 | −34.0% |
| InterCure | $5.23 | −0.18% | $62.1M | — | — | — | — |
| Median | — | — | 0.8 | −4.2% |